PREMIER/TransPharm workshop on sustainable pharmaceuticals20 April 2023 - 17:17
Meet our Scientific Advisory Board: Interview with Helmut Segner18 April 2023 - 17:14
PREMIER works on a multi-season study to monitor pharmaceuticals in surface water across Europe18 April 2023 - 16:50
PREMIER partners will present at SETAC Europe 33rd annual meeting in Dublin: don´t miss out!18 April 2023 - 14:11
PREMIER’s 6th General Assembly meeting to share project progress18 April 2023 - 13:35| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
The transition towards sustainable pharmaceuticals – assessing sustainability, from design & production to prescription & use
blog, GeneralPrioritization and selection of APIs using a risk-based approach
blogBy Cristiana Cannata, PhD researcher in Environmental Science at Radboud University (Nijmegen, The Netherlands) & contributor of PREMIER WP1.2 There are more than 1500 active pharmaceutical ingredients (APIs) on the European market. Residues of these APIs can eventually reach the environment and given the enormous number of human medicines being used, it is unclear which […]
Ecotoxicity testing: guidelines and evaluation
blogBy Alice Marshall, PhD researcher in Environmental Toxicology at University of York & contributor of PREMIER WP2.1; and Caroline Moermond, Sr Policy Advisor at the National Institute for Public Health and the Environment (RIVM), lead of PREMIER WP4 and contributor of WP3. With the continuous development of new and existing pharmaceuticals, investigation into the environmental legacy of active pharmaceutical […]